Asia Pacific New Born Screening Market Forecast 2019-2027

Publisher Name :
Date: 20-Mar-2019
No. of pages: 90

KEY INSIGHTS

The Asia-Pacific newborn screening market is driven by the support of government organizations promoting the initiatives in the treatment of fatal diseases in the region thereby helping the market to grow at the end of the forecast period of 2019-2027, the market is predicted to rise with a CAGR of 14.17%.

MARKET INSIGHTS

The South Korean newborn screening market contributed the highest CAGR value in 2018 owing to the increasing birth rate coupled with the newborn screening initiatives helping the market to grow in this region. As per the World Health Organization, around 0.48 million babies are born each year in South Korea which is likely to raise the adoption of newborn screening considering the complication that a newborn experiences.

Other significant markets in this region include India, China, Australia and the rest of Asia-Pacific.

Factors like raising awareness for pediatric congenital heart disease and an increase in the number of pregnant women with advanced maternal age are expected to drive the market growth in this region. Newborn screening reagents and assay kits are supposed to be the more popular product category in this market. However, a lack of skilled professionals to safely carry out these screenings is a major challenge faced by this market.

COMPETITIVE INSIGHTS

Market players like Sciex, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Cardinal Health Inc., GE Healthcare Limited, Agilent Technologies Inc., Masimo Corporation, Natus Medical Incorporated, Medtronic PLC, Thermo Fisher Scientific Inc., Neogen Labs Pvt. Ltd., Perkinelmer Inc., Zentech S.A., Waters Corporation and Trivitron Healthcare are well-known in this region.

Asia Pacific New Born Screening Market Forecast 2019-2027

Table of Contents

1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top-Down Approach
2.3. Bottom-Up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Demand For Newborn Screening Instruments Is Rising Steadily
3.2.2. Growth In Dry Blood Spot Test
3.2.3. Techniques Used In Newborn Screening Tests
4. Market Dynamics
4.1. Etymology Of Newborn Screening
4.2. Market Scope & Definition
4.3. Market Drivers
4.3.1. Increase In Occurrences Of Newborn Diseases
4.3.2. Growing Number Of Infants With Birth Defect
4.3.3. Backing Of Government Towards Newborn Child Health
4.3.4. Rising Awareness For Pediatric Congenital Heart Disease
4.4. Market Restraints
4.4.1. Absence Of Proper Healthcare Infrastructure For Newborn Babies In Developing Countries
4.4.2. Socio-Economic Hurdles In The Implementation Of Newborn Child Screening
4.5. Market Opportunities
4.5.1. Increasing Fertility Rates Across The Globe Is Creating Dynamic Growth
4.5.2. Newborn Screening Helps In Early Identification And Management Of Affected Newborns
4.5.3. Technological Advancements In Newborn Screening
4.5.4. Increase In Number Of Pregnant Women With Advanced Maternal Age
4.6. Market Challenges
4.6.1. Dearth Of Skilled Professional In Healthcare Industry
4.6.2. Maintenance Of Equipment In Hospital
5. Market By Product
5.1. New-Born Screening Instruments
5.2. New-Born Screening Reagents & Assay Kits
6. Market By Test Type
6.1. Hearing Screen Test
6.2. Critical Congenital Heart Disease (Cchd) Test
6.3. Dry Blood Spot Test
7. Market By Technology
7.1. Tandem Mass Spectrometry
7.2. Pulse Oximetry
7.3. Enzyme Based Assays
7.4. Dna Based Assays
7.5. Electrophoresis
7.6. Others
8. Key Analytics
8.1. Porters Five Force Model
8.1.1. Threat Of New Entrants
8.1.2. Threat Of Substitute
8.1.3. Bargaining Power Of Suppliers
8.1.4. Bargaining Power Of Buyers
8.1.5. Threat Of Competitive Rivalry
8.2. Key Buying Criteria
8.2.1. Reliability
8.2.2. Cost
8.2.3. Availability
8.2.4. Technological Advancement
8.3. Opportunity Matrix
8.4. Vendor Landscape
8.5. Value Chain Analysis
8.5.1. Raw Material Suppliers
8.5.2. Manufacturers
8.5.3. Distributors
8.5.4. End-Users
8.6. Legal, Policy & Regulatory Framework
9. Asia Pacific
9.1. China
9.2. India
9.3. Japan
9.4. Australia
9.5. South Korea
9.6. Rest Of Asia Pacific
10. Competitive Landscape
10.1. Market Share Analysis
10.2. Corporate Strategies
10.2.1. Product Launch
10.3. Company Profiles
10.3.1. Sciex
10.3.1.1. Overview
10.3.1.2. Product Portfolio
10.3.1.3. Strategic Initiatives
10.3.1.4. Scot Analysis
10.3.2. Biotek Instruments Inc
10.3.2.1. Overview
10.3.2.2. Product Portfolio
10.3.2.3. Strategic Initiatives
10.3.2.4. Scot Analysis
10.3.3. Bio-Rad Laboratories Inc
10.3.3.1. Overview
10.3.3.2. Product Portfolio
10.3.3.3. Strategic Initiatives
10.3.3.4. Scot Analysis
10.3.4. Cardinal Health Inc
10.3.4.1. Overview
10.3.4.2. Product Portfolio
10.3.4.3. Strategic Initiatives
10.3.4.4. Scot Analysis
10.3.5. Ge Healthcare Limited
10.3.5.1. Overview
10.3.5.2. Product Portfolio
10.3.5.3. Strategic Initiatives
10.3.5.4. Scot Analysis
10.3.6. Agilent Technologies Inc.
10.3.6.1. Overview
10.3.6.2. Product Portfolio
10.3.6.3. Strategic Initiatives
10.3.6.4. Scot Analysis
10.3.7. Masimo Corporation
10.3.7.1. Overview
10.3.7.2. Product Portfolio
10.3.7.3. Strategic Initiatives
10.3.7.4. Scot Analysis
10.3.8. Natus Medical Incorporated
10.3.8.1. Overview
10.3.8.2. Product Portfolio
10.3.8.3. Strategic Initiatives
10.3.8.4. Scot Analysis
10.3.9. Medtronic Plc
10.3.9.1. Overview
10.3.9.2. Product Portfolio
10.3.9.3. Strategic Initiatives
10.3.9.4. Scot Analysis
10.3.10. Thermo Fisher Scientific Inc.
10.3.10.1. Overview
10.3.10.2. Product Portfolio
10.3.10.3. Strategic Initiatives
10.3.10.4. Scot Analysis
10.3.11. Neogen Labs Pvt. Ltd.
10.3.11.1. Overview
10.3.11.2. Product Portfolio
10.3.11.3. Strategic Initiatives
10.3.11.4. Scot Analysis
10.3.12. Perkinelmer Inc.
10.3.12.1. Overview
10.3.12.2. Product Portfolio
10.3.12.3. Strategic Initiatives
10.3.12.4. Scot Analysis
10.3.13. Zentech S.A.
10.3.13.1. Overview
10.3.13.2. Product Portfolio
10.3.13.3. Strategic Initiatives
10.3.13.4. Scot Analysis
10.3.14. Waters Corporation
10.3.14.1. Overview
10.3.14.2. Product Portfolio
10.3.14.3. Strategic Initiatives
10.3.14.4. Scot Analysis
10.3.15. Trivitron Healthcare
10.3.15.1. Overview
10.3.15.2. Product Portfolio
10.3.15.3. Strategic Initiatives
10.3.15.4. Scot Analysis

List of Tables

Table 1. Asia Pacific Newborn Screening Market, By Country, 2019-2027 (In $ Million)
Table 2. Asia Pacific Incidence Of Chromosomal Abnormalities In Newborns
Table 3. Infant Mortality Rate In Developing Countries (Total Death/ 1000 Live Births)
Table 4. Asia Pacific Newborn Screening Market, By Product, 2019-2027, (In $ Million)
Table 5. Asia Pacific Newborn Screening Market, By Test Type, 2019-2027, (In $ Million)
Table 6. Asia Pacific Newborn Screening Market, By Technology, 2019-2027, (In $ Million)
Table 7. Opportunity Matrix
Table 8. Vendor Landscape
Table 9. Regulatory Framework
Table 10. Asia Pacific Newborn Screening Market, By Country, 2019-2027, (In $ Million)
Table 11. List Of Product Launches

List of Figures

Figure 1. Asia Pacific New-Born Screening Instruments Market, By Technology, 2018 & 2027 (In %)
Figure 2. Causes Of Death Among Newborns Asia Pacific (0-27 Days)
Figure 3. Fertility Rate (Average Births Per Woman In %) 2017
Figure 4. Asia Pacific Newborn Screening Market, By New-Born Screening Instruments, 2019-2027 (In $ Million)
Figure 5. Asia Pacific Newborn Screening Market, By New-Born Screening Reagents & Assay Kits, 2019-2027 (In $ Million)
Figure 6. Asia Pacific Newborn Screening Market, By Hearing Screen Test, 2019-2027 (In $ Million)
Figure 7. Asia Pacific Newborn Screening Market, By Critical Congenital Heart Disease (Cchd) Test, 2019-2027 (In $ Million)
Figure 8. Asia Pacific Newborn Screening Market, By Dry Blood Spot Test, 2019-2027 (In $ Million)
Figure 9. Asia Pacific Newborn Screening Market, By Tandem Mass Spectrometry, 2019-2027 (In $ Million)
Figure 10. Asia Pacific Newborn Screening Market, By Pulse Oximetry, 2019-2027 (In $ Million)
Figure 11. Asia Pacific Newborn Screening Market, By Enzyme Based Assays, 2019-2027 (In $ Million)
Figure 12. Asia Pacific Newborn Screening Market, By Dna Based Assays, 2019-2027 (In $ Million)
Figure 13. Asia Pacific Newborn Screening Market, By Electrophoresis, 2019-2027 (In $ Million)
Figure 14. Asia Pacific Newborn Screening Market, By Others, 2019-2027 (In $ Million)
Figure 15. Porter's Five Force Analysis
Figure 16. Key Buying Impact Analysis
Figure 17. Value Chain Analysis
Figure 18. Asia Pacific Newborn Screening Market, Regional Outlook, 2018 & 2027 (In %)
Figure 19. China Newborn Screening Market, 2019-2027 (In $ Million)
Figure 20. India Newborn Screening Market, 2019-2027 (In $ Million)
Figure 21. Japan Newborn Screening Market, 2019-2027 (In $ Million)
Figure 22. Australia Newborn Screening Market, 2019-2027 (In $ Million)
Figure 23. South Korea Newborn Screening Market, 2019-2027 (In $ Millions)
Figure 24. Rest Of Asia Pacific Newborn Screening Market, 2019-2027 (In $ Million)
Figure 25. Industry Player Positioning In 2018 (In %)
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs